Table 2 Logistic regression analysis and age-stratified analyses results for the association between serum hs-CRP levels and ED.
Variable | Number | Unadjusted | Age-adjusted | Multivariate-adjusted* | |||
---|---|---|---|---|---|---|---|
ALL participants | (n = 1515) | OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value |
Quartile of hs-CRP | |||||||
Q1 (<0.24 mg/L) | 377 | 1 | 1 | 1 | 1 | 1 | 1 |
Q2 (0.24–0.53 mg/L) | 372 | 1.19 (0.88, 1.61) | 0.258 | 1.10 (0.80, 1.49) | 0.563 | 1.08 (0.79, 1.48) | 0.62 |
Q3 (0.54–1.22 mg/L) | 380 | 1.47 (1.09, 1.98) | 0.011 | 1.20 (0.88, 1.63) | 0.257 | 1.19 (0.87, 1.64) | 0.283 |
Q4 (>1.22 mg/L) | 386 | 1.80 (1.35, 2.42) | <0.001 | 1.51 (1.12, 2.05) | 0.008 | 1.50 (1.08, 2.08) | 0.015 |
P-value for trend | Â | Â | <0.001 | Â | <0.001 | Â | 0.003 |
Young group | (n = 985) |  |  |  |  |  |  |
Q1 (<0.20 mg/L) | 259 | 1 | 1 | 1 | 1 | 1 | 1 |
Q2 (0.21–0.47 mg/L) | 243 | 1.18 (0.80, 1.74) | 0.395 | 1.15 (0.78, 1.69) | 0.44 | 1.18 (0.80, 1.75) | 0.406 |
Q3 (0.48–1.16 mg/L) | 246 | 1.40 (0.96, 2.04) | 0.083 | 1.34 (0.91, 1.96) | 0.137 | 1.41 (0.94, 2.10) | 0.093 |
Q4 (>1.16 mg/L) | 237 | 1.62 (1.11, 2.37) | 0.012 | 1.56 (1.07, 2.28) | 0.022 | 1.72 (1.13, 2.59) | 0.011 |
Middle aged and elderly group | (n = 530) |  |  |  |  |  |  |
Q1 (<0.32 mg/L) | 132 | 1 | 1 | 1 | 1 | 1 | 1 |
Q2 (0.33–0.67 mg/L) | 133 | 1.22 (0.75, 1.98) | 0.42 | 1.21 (0.74, 1.99) | 0.441 | 1.13 (0.68, 1.89) | 0.628 |
Q3 (0.68–1.42 mg/L) | 133 | 1.42 (0.87, 2.30) | 0.157 | 1.30 (0.79, 2.13) | 0.307 | 1.17 (0.70, 1.97) | 0.553 |
Q4 (>1.42 mg/L) | 132 | 2.46 (1.50, 4.04) | <0.001 | 2.31 (1.39, 3.84) | 0.001 | 2.02 (1.18, 3.47) | 0.011 |
P-value for trend | Â | Â | <0.001 | Â | <0.001 | Â | <0.001 |